153 related articles for article (PubMed ID: 27294610)
1. Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.
Hirko KA; Fortner RT; Hankinson SE; Wu T; Eliassen AH
Breast Cancer Res Treat; 2016 Jul; 158(1):149-155. PubMed ID: 27294610
[TBL] [Abstract][Full Text] [Related]
2. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies.
Sisti JS; Lindström S; Kraft P; Tamimi RM; Rosner BA; Wu T; Willett WC; Eliassen AH
Breast Cancer Res Treat; 2015 Jun; 151(2):415-25. PubMed ID: 25917867
[TBL] [Abstract][Full Text] [Related]
3. Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study.
Fortner RT; Tworoger SS; Wu T; Eliassen AH
Breast Cancer Res Treat; 2013 Sep; 141(2):307-16. PubMed ID: 24046001
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte membrane fatty acids and breast cancer risk: a prospective analysis in the nurses' health study II.
Hirko KA; Chai B; Spiegelman D; Campos H; Farvid MS; Hankinson SE; Willett WC; Eliassen AH
Int J Cancer; 2018 Mar; 142(6):1116-1129. PubMed ID: 29071721
[TBL] [Abstract][Full Text] [Related]
5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
6. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study.
Yang S; Giovannucci E; Bracken B; Ho SM; Wu T
BMC Urol; 2015 Aug; 15():85. PubMed ID: 26272213
[TBL] [Abstract][Full Text] [Related]
8. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
10. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
12. Healthy Dietary Patterns and Oxidative Stress as Measured by Fluorescent Oxidation Products in Nurses' Health Study.
Jung S; Smith-Warner SA; Willett WC; Wang M; Wu T; Jensen M; Hankinson SE; Eliassen AH
Nutrients; 2016 Sep; 8(9):. PubMed ID: 27657128
[TBL] [Abstract][Full Text] [Related]
13. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
14. Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
Wang Y; Gapstur SM; Gaudet MM; Furtado JD; Campos H; McCullough ML
Cancer Causes Control; 2015 Sep; 26(9):1233-44. PubMed ID: 26081425
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Heng YJ; Wang J; Ahearn TU; Brown SB; Zhang X; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; DuPre NC; Garcia-Closas M; Troester MA; Hunter DJ; Eliassen AH; Tamimi RM; Hankinson SE; Beck AH
Breast Cancer Res Treat; 2019 Feb; 173(3):667-677. PubMed ID: 30387004
[TBL] [Abstract][Full Text] [Related]
16. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
17. Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: a prospective study.
Yang S; Feskanich D; Willett WC; Eliassen AH; Wu T
J Bone Miner Res; 2014 Dec; 29(12):2577-83. PubMed ID: 24957524
[TBL] [Abstract][Full Text] [Related]
18. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
20. Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study.
Zhang M; Zhang X; Qureshi AA; Eliassen AH; Hankinson SE; Han J
PLoS Med; 2014 Jun; 11(6):e1001659. PubMed ID: 24915186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
